Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Interrelationship Between Sensory Modulation, Altered Interoceptive Awareness, And Anxiety And Impacts On Quality Of Life, Sara Laughter, Vanessa Mitchell, Natalie Nguyen, Christine Kim May 2020

Interrelationship Between Sensory Modulation, Altered Interoceptive Awareness, And Anxiety And Impacts On Quality Of Life, Sara Laughter, Vanessa Mitchell, Natalie Nguyen, Christine Kim

Occupational Therapy | Graduate Capstone Projects

OBJECTIVE: The negative impacts of sensory modulation disorder (SMD), anxiety, and altered interoceptive awareness (AIA) on daily occupations reinforced the need for the study of the relationship between sensory modulation, anxiety, and interoception in typical adults. Understanding the relationship between the three constructs is the first step in the ultimate goal of developing effective intervention and treatment measures.

METHODS: This cross-sectional, exploratory study analyzed the relationship between scores on four self-report measures in an online survey: State Trait Anxiety Inventory (STAI), 36-Item Short Form Health Survey (SF-36), Sensory Responsiveness Questionnaire (SRQ), and Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). …


Psilocybin-Assisted Psychotherapy: Treating Depression And Anxiety With Mushrooms, Sofia Beck Jan 2020

Psilocybin-Assisted Psychotherapy: Treating Depression And Anxiety With Mushrooms, Sofia Beck

Physician Assistant Studies | Student Articles

Depression and anxiety are debilitating mental health conditions that affect a large portion of the United States. Current pharmacological treatments for these disorders require daily administration, are associated with a number of side effects, and can be ineffective for some. Emerging evidence in novel treatment options may necessitate a shift toward how we treat these psychiatric disorders.

Studies involving the psychedelic serotonin agonist, psilocybin, are currently experiencing a resurgence as an alternative for patients who are unresponsive to traditional treatments. Clinical trials using psilocybin in combination with psychotherapy have demonstrated sustained reductions in depression and/or anxiety symptoms. When used in …